INNOVATIVE EYEWEAR, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
INNOVATIVE EYEWEAR, INC. (LUCY) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$4.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$2.13M, a 181.12% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $2.63M.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$1.64M.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$141.28K.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $3.88M.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$1.66M, a 338.17% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $696.34K, a 80.17% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $3.51M, a 6562.46% increase from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.06M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$2.13M 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $3.88M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $4.07M 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $5.00M 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $2.63M 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$1.66M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $256.38K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $1.61M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$1.64M 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $696.34K 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $312.56K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $1.77M 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | -$141.28K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $3.51M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $4.90M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$44.85K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$37.98K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $52.70K 10-K · filed 2023-03-24 | |||
| 2021-09-30 | $38.03K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $98.62K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |